The resistance of certain bacteria to antibacterial drugs has been appreciated since these drugs were introduced into the medical arn1amentarium. The basis for bacterial drug resistances was not defined until somewhat later, however. Bacteria are now known to be drug resistant either because of some alterable property ofthe bacteria or the environment ('phenotypic resistance') or a more pern1anent property mediated by a chromosomal or extrachromosomal resistance gene ('genotypic resistance'). Certain aspects of each of these phenon1ena are summarized in this review but particular emphasis is given to the resistance n1ediated by the extrachromosomal resistance (R) factors of the enteric bacilli.
GENETIC BASIS OF RESISTANCE
Certain examples of alterable or 'phenotypic' drug resistance of bacteria are presented in Table 1 . All antibacterial drugs, with the exception of the polyn1yxins, inhibit only bacteria actively synthesizing macromolecules. For example, concentrations of streptomycin (Str) that are bactericidal for actively growing bacteria have no effect on the same cells if their protein synthesis is stopped by chloramphenicol (Cml) or the deprivation of a required nutrient 1 . Although the composition and quantity of the bacterial envelope is genetically regulated, these properties can be altered by manipulations of the environment, which, in turn, may alter the susceptibility of the cell to certain known for its 'gram-positive' spectrum, is very effective against spheroplasts of 'resistant' Proteus mirabilis 4 . Bacteria deficient in cell wall are 'phenotypically' resistant to antibacterial drugs, e.g. the pencillins, bacitracin, vancomycin, that inhibit wall synthesis.
The composition of the environmental milieu has a profound effect on the interaction between certain drugs and bacteria. The antibacterial activity of novobiocin, Chlortetracycline and mandelic acid is enhanced by acid pH's while that of the aminoglycoside drugs and erythromycin is considerably enhanced by alkaline pH's 5 . The minimal inhibitory concentration of streptomycin (Str) for Staphylococcus aureus, for example, is 100 times greater at pH 7.7 than at pH 5.2 6 • Other environmental factors that affect the antibacterial activity of certain drugs include cation concentration and composition, state of oxygenation, and concentration of nutrients that interfere with the action of the drug.
These are only a few of the defined factors that affect the interaction of drug and bacteria. Indeed, it seen1s likely that much, if not most, of the resistance of bacteria in nature to drugs is due to 'phenotypic' mechanisms.
Until recently, the genetic basis of bacterial drug resistance was thought tobe due to a mutation ofthe chromosomal gene mediating drug susceptibility. The existence of extrachron1osomal genetic elements that mediate drug resistance has now been well documented inS. aureus and the enteric bacilli, and their presence in S. albus 7 and group D Streptococci 8 is suggested by recent studies. It is not possible to review the properties of all extrachromosomal elements n1ediating drug resistance, so only those of the R factors of enteric bacilli will be presented. Some of the more important of these properties are summarized and contrasted to those of the resistances mediated by a chromosomal mutation in Table 2 .
PROPERTIES OF R FACTORS

Molecular basis
Whereas a cell with a mutation mediating drug resistance has an alteration in a locus on its chromosome, that infected by an R factor must have some genetic material other than its chromosome. Considerable effort has been expended to define the natureoftheR factor genetic material. The molecular basis of the R factors was presumed to be DNA; therefore, in the initial studies, CsCl gradients of DNA purified from R + Escherichia coli were examined for a satellite band, vide infra, the R factor genon1e. When no satellite DNA was observed, it was reasoned that the DNA of E. coli, which is 50 per cent G-C 9 , and R factors have a similar composition. The studies were therefore repeated with R + P. mirabilis, whose chromosomal DNA has a G-C composition of 36 per cent 9 . A satellite band with a heterogeneaus composition of 44-50 per cent was observed in the CsCl gradients of DNA purified from R +, but not R-, P. mirabilis 10 • 11 . Following the demonstration that the R factor genome is a closed circle (see below), the earlier experiments with DNA of R + E. coli have been repeated using gradients which separate linear and circular DNA of the same composition: circular units presumed tobetheR factor genome have been observed in extracts of R +, but not R-, E. coli 12 -14 . These observations have been supported and extended by recent studies employingthe so-called 'mini-cells', the small cellular units that Iack chromosomal DNA produced by certain strains of E. coli 15 • Mini-cells produced by R +, but not R-, strains contain DNA with the properties described fortheR factor by earlier studies 16 . Genetic studies 17 • 18 have indicated that an R factor is a composite of two functionally separate units: a transfer unit, or RTF, that mediates conjugal fertility, and, in some cases, restriction of certain phages 18 ; and another unit (RD) mediating the drug resistances. Cells with the genetic properties of either or both units can be selected from a parent R + bacteriun1. The most recently reported studies of R factor DNA in P. mirabilis indicate that the heterogeneity observed earlier in the sedimentation properties of the R factor DNA is due to the presence of three distinguishable units, presun1ably the RTF, the RD and the complete R factor 12 -14 • lndeed, DNA presun1ed to be that of the RTF has been identified in cells possessing conjugal fertility (RTF+) but no drug resistance (RD-) derived fron1 an R + strain 19 . Electron micrographs of these purified DNA preparations indicate that, like the E. coli chromosome, the DNA of a complete R factor and that ofthe composite RTF and RD, are covalently closed circles 13 • 14 . Genetic transmission Although the interbacterial transfer of an R factor can be n1ediated by transduction, it is presumed to occur more commonly in nature by conjugation. A schematic model of the conjugal transfer of R factors is depicted in Figure 1 . The kinetics of such transfer of a wild type R factor between two strains of E. coli in vitro are illustrated in Figure 2 . lt is evident that during the course ofthe experiment the numbers oftotal donor and recipient bacteria increase in parallel whereas recipient bacteria acquiring an R factor increase at a much more rapid rate, particularly initially, until they constitute about 0.01---0.1 per cent of the total population of recipient cells. This experiment also illustrates that the conjugal transfer of R factors can be prevented by diluting the bacteria to approximately 10 6 /nll, a concentration at which the randon1 interbacterial collisions that are required for specific conjugal contacts are too few to be significant.
In addition to the concentration of donor and recipient bacteria, certain properties of the involved bacteria, the R factors and the environment affect the conjugal transfer of R factors. Transfer is much greater between bacteria of the same, rather than unrelated, genera, and mutant bacteria deficient in cell envelope antigens are up to 100 x more effective as donors (and recipients) of R factors than are their parent cells 20 . Since bacteria deficient in cell envelope antigens are less virulent than their parents, these findings have been cited as evidence for the non-pathogenicity ofR + bacteria. Such statements, however, do not take into account the facts that R factors infect cells with normal cell envelopes in vitro and that many of the resistant enteric bacilli isolated from sites of human disease possess R factors and all cell envelope antigens.
The capacity of R factors to produce the sexual pilus required for conjugation is normally quite restricted; cells containing mutant R factors which have an increased capacity to produce such pili are 100-1000 x more This contact in some inknown way triggers a round of replication oftheR factor, during which one copy ofit is transferred to the recipient cell, while the other copy is retained within the donor cell. At the conclusion ofthe process, 3, both bacteria possess R factors and are drug resistant and potential conjugal donors oftheR factor.
active as R factor donors 21 . The state of the current knowledge of this aspect of R factor transfer has recently been reviewed by the Meynells and Datta 22 . Conjugal transfer ofR factors in vitro is inhibited by a nurober ofsubstances found in body fluids, non-physiological pH's, anaerobiosis, and inhibitors of DNA synthesis 2 3 . Considering the nurober of factors that roay adversely affect the conjugal transfer ofR factors, it is not surprising that the kinetics of transfer in vivo differ n1arkedly froro those observed in vitro 24 .
Phenotype
Resistances to sulphonamides (Sul), tetracycline (Tet), Crol and Str were the first associated with R factors. Subsequently, resistance to certain nonantibiotic antibacterial agents, e.g. bacteriophages, salts ofheavy roetals, and ultra-violet light, and most of the other antibacterial drugs used to treat infections caused by enteric bacilli were found to be roediated by certain R factors (Table 3) . Conspicuously absent from this list of resistances, however, are those to the furan derivatives and nalidixic acid (Nal), although the liberal use of these drugs in medicine or agriculture roight be presuroed 275,626(1966) to have provided ample opportunity for the selection of R factors with these resistances. The possibility that this negative association is related to the synthetic rather than natural origin of the furans and Nal remains a matter of speculation. All other drugs, with the exception of sulphonamides, to which R factors mediate resistance are produced by microorganisms found in nature. The 'natural' antibiotics may, therefore, have been exerting a selective pressure on enteric bacilli and their evolution for a considerably Ionger period than compounds only recently synthesized and introduced into nature by man. A number of other possible explanations for this negative relationship exist, however, including the possibility that all genes n1ediating resistance to the furans and Nal are recessive when introduced into bacteria possessing a gene mediating susceptibility to the respective drugs. The genetics of resistances to these drugs has not been studied in bacteria isolated from nature, but the locus mediating Nal resistance in E. coli selected in the Iabaratory is recessive when introduced into Nal 8 E. coli by an F factör 25 . Definition oftbis type of question regarding the origin ofR factor genes is of practical, as weil as theoretical, importance. The epidemiology of R factors is beyond the scope of this review. lt must be emphasized, however, that R factors, described originally as mediators of resistance to three or more drugs, often mediate resistance to only one or a few drugs. Furthermore, the patterns of resistance mediated reflect, in part, the environment in which the host bacteria were isolated. Thus, R factors n1ediating the patterns of resistance described originally in Japan are rarely observed in bacteria isolated in the United States Table 3 contrasts certain of the known biochemical mechanisms for the resistances mediated by R factors and by chromosomal mutations. Whereas most of the studied R factor resistances are mediated by enzymes that inactivate the respective drugs, the studied resistances due to chromosomal mutations are generally mediated by altered structural proteins or synthetic enzymes. It should be en1phasized, however, that chromosomal resistance has been studied, until recently, in only a few species of a few genera of bacteria, all of which have been selected for resistance in the laboratory. The recent reports that drug-resistant strains of certain R-E. coli, P. mirabilis and Pseudomonas aeruginosa produce ß-lactamase 29 , chloramphenicol acetyl transferase 30 • 31 • 38 and kanamycin phosphorylase 32 , respectively suggest that the earlier studies on the biochemical basis of drug resistance following chromosomal mutations of enteric bacilli may have been incomplete, and they en1phasize the importance of studying resistant bacteria isolated from nature.
BIOCHEMICAL BASIS F'OR RESISTANCE
lt might be presumed that resistance mediated by a drug-inactivating enzyn1e should be expressed as soon as the enzyme is synthesized, whereas that mediated by an altered or 'drug-resistant' protein may not be expressed until its concentration surpasses that of the protein mediating susceptibility to the drug. lt is, therefore, not surprising that all of the R factor resistances studied are expressed within a fraction of a generation time of the host cell following the introduction into the cell of an R factor, and that, on the other hand, many resistances mediated by chromosomal mutation, e.g. Str resistance, are not expressed for several generation times following the mutational event or the introduction of the mutant gene by genetic transfer.
The biochemical basis fortheR factor-mediated resistances have been the subject of experimentation in many laboratories, and many of these mechanisms have been defined.
Resistance to Cml (Figure 3) is produced by an enzyme ( Table 4) The Cml acetyltransferase (CAT) attacks only those Cml congeners with the D, threo configuration; it also requires a substrate that contains an acyl group at the 2-amino position of the molecule, but it tolerates substrates in which the 1-phenyl group is substituted (Table 5) 34 . Thus, while the enzyme attacks many biologically inactive analogues, it acetylates all known Cml congeners that have antibiotic activity. The available data indicate that both acetoxy compounds are produced by one enzyme. The reduced antibacterial activity of these compounds, like those of previously described nonantibacterial Cml analogues 35 , appears to be due to their reduced binding affinity for ribosomes 36 , the site of action of Cml. Following the documentation of CAT as the basis for the R factormediated resistance, this enzyme has been observed in certain R-strains of enteric bacilli. Some, but not all, Cml 'sensitive' P. mirabilis produce small amounts of CAT 37 • Mutants of these strains selected for high Ievels of resistance to Cml, produce high er concentrations of CAT than do the parent strains. Jacobson and Shaw have reported that the CAT of P. mirabilis and R factors are similar with respect to molecular weights, substrate specificities, for the CAT of R-P. mirabilis and 0.68 x 10-5 M for R + strains 38 . These data suggest an evolutionary relationship between the presumed chromosomal gene and the R factor gene that mediates CAT synthesis, but further genetic sturlies will be needed to prove that the CA T locus of R factors came originally from P. mirabilis. The properties of the CAT produced by an apparently R-strain of E. coli b maintained in the laboratory of Sompolinsky 31 , but not in that of other investigators, remain to be described. CAT with similar, but not identical, properties is also produced by Cml resistant S. aureus 39 , S. albus 40 , and group D Streptococci 8 , and, in each case, the genetic apparatus for these enzymes appears tobe located on an extrachromosomal element. b nmoles p-nitro-m-carboxythio-phenol produced per min per mg protein at 25°C.
• cpm of ot· 32 P·ATP pr JlS aliquot which adsorb to a 1 cm 2 piece of phospho· cellulose paper per J.lg protein per min at 37°C. There have been few studies of the regulation of R factor enzymes, but the data of Harwood and Smith indicate that the synthesis by E. coli of the R factor-mediated CAT is affected by the carbon source in the n1edium: the specific activity of the enzyme in cells grown in glucose or glucose-6-phosphate is ~ ~ that of cells grown in glycerol or succinate (Table 6) 41 • This catabolite repression is eliminated by the addition of 5mM cyclic 3'5' AMP to the culture medium ( Table 7 ). The role of cyclic AMP on the regulation of CAT synthesis is supported and emphasized by the very low specific activity ofthe enzymein a mutant strain of E. coli that is deficient in cyclic AMP (Table 8 ). Catabolite repression of the synthesis of an R factor enzymewas not anticipated since, to our knowledge, this is the first report of constitutive enzyme synthesis being subject to this form of control, and since such enzymes have no known catabolic function. These results may, therefore, provoke a re-examination of these enzymes' evolutionary origins and/or role in the cell. • units as in Table 6 . R factors produce two enzymes that in the presence of ATP inactivate Str by attacking the 3-0H group of the N -methyl glucosan1ine moiety of the drug (Figure 4) . The better studied of these enzymes, the Str adenylate (Table 9) attacks Str, a number of Str analogues and spectinon1ycin (Spc), an aminoglycoside antibiotic that differs from Str in that it is bacteriostatic and does not promote genetic miscoding 45 ; SA T does not attack the neomycins, kanamycins or gentamicins, however. Like all other R factor enzymes studied, the SA T is produced constitutively, and preliminary studies indicate that its synthesis, like that of CA T, is also catabolite repressed (Table 5) 41 48 by Umezawa's group, and it will be ofinterest to hear more about the biology of these enzymes as weil as their relation to that produced by R + enteric bacilli. Davies has found that the Iack of antibacterial activity of Str adenylate and Str phosphate is due to their markedly reduced binding affinity for ribosomes (personal communication).
R factors produce two enzymes that in the presence of ATP inactivate kanamycin (Kan) by acetylating the 6-amino group 49 or phosphorylating the 3-0H group 50 of the 6-amino-6-deoxy-n-glucose moiety ( Figure 5 ). The Kan phosphorylase is genetically and biochemically distinct from the Str phosphorylase, and, not surprisingly, the Kan acetyltransferase (KAT) is not related to the CAT. The site attacked by the KAT is relatively unique to Kan and thus the enzyme .does not inactivate structurally similar aminoglycoside drugs in which the above moiety is substituted by other groups, e.g. Kan C (glucosamine), Neo (2-6-diamino, 2-6-dideoxy-n-glucose) or Par (2-6-diamino 2-hydroxy-6-dioxy-n-glucose) 49 . KAT does acetylate gentamiein (Gen) C 1 a and C 2 , however ( Figure 6 ) (Davies, J., personal communication). The Kan phosphorylase attacks the C 3 group of the 6-amino-6-deoxy-n-glucose moiety of Kan and Neo, and of the glucosamine moiety of Par 5°. Thus, the enzymatic basis for the Kan resistance of certain enteric bacilli can be preliminarily evaluated by the pattern of resistance to these related aminoglycoside drugs.
Gen C has no oxygen function at the C 3 position of the methyl amino sugar 51 and, thus, is not attacked by the SAT, Str phosphorylase or Kan phosphorylase. The acetylation of Gen C by the KAT reduces but, unexpectedly, does not eliminate, the antibacterial activity of the drugs (Davies, J., personal communication); thus, bacteria with an R factor producing this enzyme are resistant to Kan but not Gen. Martin, at a recent syn1posium on gentamicin, reported that certain highly Gen resistant strains of Klebsiella isolated in clinics in the United States contain an R factor that apparently inactivates Gen and Kan but not Str. This resistance has been found to be mediated by an enzyme that adenylates the drug 63 . This finding is rather sobering since Gen has been used commercially in this country for less than two years, and it re-emphasizes the need for a better definition of the origin of R factor genes. Many enteric bacteria produce ß-lactamases that inactivate certain penicillins and/or cephalosporins. Several recent reports have clarified the questions of the number and type of these enzymes, and their relationship to bacterial resistance. When Jack and Richmond 52 studied the profile, charge, and sensitivity to p-chlormercuribenzoate, cloxacillin and antiserum of the ß-lactamases produced by 4b ampicillin resistant strains of eight genera of enteric bacilli, they found eight distinct enzymes (Table 10) . Some were predominantly 'penicillinases', other 'cephalosporinases', while others were equally active against penicillins and cephalosporins. Twelve of the 46 strains, including some producing three of the eight types of ß-lactamases, transferred by conjugation the gene(s) mediating the synthesis of these enzymes. The prevalence and distribution of R factors producing these enzymes has not yet been defined 53 - 55 . The carbenicillin resistance of certain P. aeruginosa strains isolated in Great Britain 56 is mediated by one of the eight enzymes found in the Enterobacteriaciae, and is produced by an R factor 57 • 58 There is little question that the ß-lactamases ofR factors contribute to the ampicillin and cephalosporin resistances of host bacteria. On the other hand, non-enzyn1atic mechanisms, due, at least in part, to alterations in permeability to the drugs, can mediate these resistances in enteric bacilli in the absence of ß-lactamase. It is therefore of interest that some R factors can produce such non-enzymatic resistance to the penicillins 59 .
Origin
The results of recent sturlies are beginning to define the ongm ot the R factor genome. Relationship to other bacterial plasmids, e.g. colicinogenic factors 60 and bacteriophage, is indicated by the recombination of R factors with these elements. That some part of the R factor genome is related to the chromoson1e of bacteria is evidenced by the integration of certain R factors into the E. coli chromosome 61 and the discovery of an R factor bearing a complete lac operon 62 • The biochemical similarities between certain enzymes produced by R factors and apparently R-bacteria suggest, but do not prove, a common origin of the genes producing these enzymes. The available data do not indicate, for example, whether the R factor genes originated in the bacteria, or whether the enzyme synthetic genes in the bacteria are integrated segments of an R factor genome. In any event, the picture that is being developed for the origin of R factors is that of a complex 'quilt' of genes of multiple origins brought tagether by multiple recombinational events under the selectial pressure of antibiotics in the environment.
